Among other things, there is no guarantee that planned or ongoing studies will be completed as planned, that future study results will be consistent with expectations or study results to date, that retatrutide will prove to be a safe and effective treatment for obesity or overweight and knee osteoarthritis or other potential indications, that retatrutide will receive regulatory approval, or that Lilly will execute its strategy as expected
If you believe a GLP-1 RA medicine such as Ozempic made you sick or hurt you, our law firm has the resources needed to: Identify potentially harmful medicines Investigate if the medicine hurt you Review the medicine manufacturers compliance with FDA regulations Examine the adequacy of the manufacturer's warning to you about potential side effects Review other issues that could affect your potential claim Learn more about our medical drug experience here
Results from two late-stage clinical trials show that tripling the standard dose of semaglutide can significantly increase weight loss in individuals with obesity, both with or without a type 2 diabetes diagnosis
But its important to get a treatment plan from a healthcare professional who is well-versed in both menopause and weight loss
Zhao J, Zhang Y, Wei F et al (2019) Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts
